Loading insider details...
Beta
Latest Form 4 (Oct 16, 2026): Grant/Award of 20,300 IAM shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 16, 2026 | Iambic Therapeutics, Inc. (IAM) | Grant/Award | 20,300 | n/a |
| Jun 30, 2026 | Septerna, Inc. (SEPN) | Grant/Award | 15,000 | n/a |
| Jun 15, 2026 | BeOne Medicines Ltd. (ONC) | Grant/Award | 18,980 | n/a |
| Jun 15, 2026 | Organon & Co. (OGN) | Grant/Award | 17,857 | $240.0K |
| May 29, 2026 | NEUROCRINE BIOSCIENCES INC (NBIX) | Grant/Award | 2,567 | n/a |
| May 21, 2026 | NEUROCRINE BIOSCIENCES INC (NBIX) | Exercise/Conversion | 1,659 | n/a |
| Jun 20, 2025 | Septerna, Inc. (SEPN) | Grant/Award | 16,623 | n/a |
| Jun 16, 2025 | Organon & Co. (OGN) | Grant/Award | 23,904 | $240.0K |
| May 22, 2025 | NEUROCRINE BIOSCIENCES INC (NBIX) | Exercise/Conversion | 1,435 | n/a |
| May 22, 2025 | BeiGene, Ltd. (BGNE) | Grant/Award | 10,985 | n/a |